Global Bio Pharma Buffer Market Growth 2023-2029

Global Bio Pharma Buffer Market Growth 2023-2029

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.

Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.

LPI (LP Information)' newest research report, the “Bio Pharma Buffer Industry Forecast” looks at past sales and reviews total world Bio Pharma Buffer sales in 2022, providing a comprehensive analysis by region and market sector of projected Bio Pharma Buffer sales for 2023 through 2029. With Bio Pharma Buffer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio Pharma Buffer industry.

This Insight Report provides a comprehensive analysis of the global Bio Pharma Buffer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio Pharma Buffer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bio Pharma Buffer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio Pharma Buffer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio Pharma Buffer.

The global Bio Pharma Buffer market size is projected to grow from US$ 823.1 million in 2022 to US$ 1362.8 million in 2029; it is expected to grow at a CAGR of 1362.8 from 2023 to 2029.

The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Bio Pharma Buffer market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Phosphates Type
Acetates Type
TRIS Type
Others

Segmentation by application
Research Institution
Pharmaceutical Industry
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bio Pharma Buffer market?

What factors are driving Bio Pharma Buffer market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bio Pharma Buffer market opportunities vary by end market size?

How does Bio Pharma Buffer break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.